ONO-2909 Phase I study Single and multiple oral dose study in healthy adult male subjects, elderly male and female subjects, and patients with narcolepsy
Latest Information Update: 05 Mar 2021
At a glance
- Drugs ONO-2909 (Primary)
- Indications Narcolepsy
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Ono Pharmaceutical
- 05 Mar 2021 New trial record.